What Researchers Did
The researchers looked back at the medical records of adults with cancer who had hyperbaric oxygen therapy at one hospital in Korea, to check blood-related safety, including in people who also had chemotherapy or traditional Korean herbal therapy.
What They Found
This retrospective study of 259 adults with cancer who had 2692 low-pressure HBOT sessions found only 2 mild treatment-emergent adverse events (0.07%) and no serious or life-threatening events. Among 207 patients with paired laboratory results, most blood and biochemical measures were stable. Platelet count fell modestly (16 x 10^3 per microlitre, adjusted p less than 0.001) and plateletcrit fell by 0.01% (p less than 0.001), but average values stayed within reference ranges. In adjusted models, chemotherapy was linked to lower white blood cell and neutrophil counts, and herbal therapy to a minor drop in eosinophils. Neither was linked to platelet changes, and subgroup comparisons showed no clinically meaningful blood differences between exposed and unexposed groups.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective review of records from a single center with no randomized comparison group, so it cannot show that HBOT caused or prevented any change, and the authors say long-term safety still needs to be confirmed.